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Two decades ago, Sawa et al. [1] published an article
entitled ‘‘New quantitative method to determine
protein concentration and cell number in the aqueous
in vivo’’ in the Japanese Journal of Ophthalmology.
This work represented a milestone in the evolution of
measurement of intra-ocular inflammation. The laser
flare (cell) photometer (LF(C)P) became commer-
cially available in 1989–1990 and this technology
promoted flare from a qualitative parameter to the
only quantitative modality we have to measure intra-
ocular inflammation.
In 1954, the first grading system of anterior intra-
ocular inflammation using slit-lamp observation of the
aqueous humor was proposed by a group of clinicians
from the Proctor Foundation and had the merit of
standardizing, at least in theory, inflammatory levels in
the anterior chamber [2]. Although the system was
supposed to set precise standards, it left a lot of space,
especially as far as flare was concerned, for inter-
observer and intra-observer variation, as it was a
subjective system based on individual interpretation of
slit-lamp findings. As far as aqueous cells were
concerned, the system was somewhat more precise as
the counting of cells with the slit-lamp is possible to a
certain extent, but it remained, nevertheless, semi-
quantitative at best. In 2004, uveitis specialists from
around the world convened in Baltimore following the
invitation of a group of American clinicians to decide
on a new standardization system for uveitis nomen-
clature (SUN workshop) and, despite the fact that LFP
had been on the market for more than 10 years and its
sensitivity and reliability had been proven without
question, the SUN workshop took over the Proctor
Criteria almost unchanged for the assessment of intra-
ocular inflammation [3].
Laser flare photometry (LFP) basically relies on the
same principles as slit-lamp evaluation of flare. As for
slit-lamp flare measurement, there is an incoming light
beam and the quantity of diffracted light, proportional
to the amount of cloudy matter in the aqueous humor
(proteins), is measured. However the non-quantifiable
polychromatic incident beam of the slit-lamp has been
replaced by a quantifiable laser beam in LFP and the
measuring device, the subjective human eye, is
replaced by an objective photomultiplier–photodetec-
tor. Many studies were performed to show the immense
superiority of this quantitative and objective method.
In this issue a review article on LFP details the different
studies that have been performed over the years [4].
Laser flare photometry was, at first, thought to be
especially suited for clinical studies on intra-ocular
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inflammation and indeed it was used in innumerable
studies. It allowed the evaluation of the anti-inflamma-
tory power of numerous topically and systematically
administered substances and enabled comparisons to be
made between the substances. A selection of the
numerous studies performed can be found in the review
article in this issue [4].
However, it is in everyday uveitis practice that
LFP technology has proven most useful. LFP-mea-
sured flare has become the only quantifiable param-
eter for most cases of intra-ocular inflammation, in
both anterior and posterior segment inflammation, as
long as in the latter there is a minimum of associated
anterior chamber flare [5]. It was shown that LFP is
not only essential in the assessment and follow-up
of acute inflammation but also in chronic disruption
of the blood–aqueous barrier. Even in the absence of
cells, LFP can detect active and treatable inflamma-
tion, as was shown in a group of patients with
juvenile idiopathic arthritis-associated uveitis, where
a significant flare reduction after introduction of
maximal therapy was demonstrated [6]. In this issue a
clinical research article shows that LFP-measured
flare is superior to slit-lamp cell count for the follow-
up of inflammation in acute cases of HLA-B27-
related uveitis [7]. In essence, LFP is to uveitis what
tonometry is to glaucoma: it allows measurement of
the level of intra-ocular inflammation at any given
time point. An interesting article in this issue also
shows that in uveitis it is possible to measure flare in
either dilated or non-dilated pupils, as no significant
difference was found [8]; however, for technical
reasons it is easier to measure flare in dilation.
Today LFP is used in many foremost centres
throughout Europe and other parts of the world.
Besides Europe, where LFP was rapidly integrated
for everyday practice in leading centres in France,
Germany, Italy, UK, Scandinavia and Switzerland,
clinical LFP studies have recently been performed in
Turkey and China [9, 10]. In this issue Yang and
colleagues have followed the evolution of flare in
Behc¸et’s uveitis [11].
Although LFCP allows the quantification of cells or
particles in the aqueous humor, it is clinically less
relevant. In clinical practice, the whole anterior
chamber is examined for the presence of cells using
the slit-lamp. The instrument, however, only evaluates
a small volume, which makes it less reliable for cells as
the distribution of cells in the anterior chamber is less
diffuse and uniform than proteins. This drawback,
present in the FC-1000 model, has been attenuated in
the FC-2000 model which uses a larger measurement
window. Nevertheless, this method allows objective
measurement and quantitative analysis of cellular or
particle numbers for the purpose of clinical studies.
This editorial comment applies only to slit-lamp
LF(C)P photometers including the Kowa-FC-1000,
Kowa FC-2000 and Kowa FM-500 models, all
extremely reliable instruments. Unfortunately, the
only company producing this technology has aban-
doned the instrument models constructed on the
principle of the slit-lamp and today only produces
one non-slit-lamp-based model, the Kowa FM-600.
Although the new type of instrument has been tested
and compared to previous models in study conditions,
in everyday uveitis practice this new instrument is less
suitable as it is fully automatic and does not allow
manual adjustments to orient the incident beam as can
be done in the slit-lamp construction principle. There-
fore, no measurement can be obtained with the Kowa
FM-600 in many uveitic eyes, especially in the
‘‘difficult’’ eyes where LFP is most required. More-
over, first results in a European setting comparing the
two types of instruments in everyday uveitis practice
also show that the Kowa FM-600 seems to be less
reliable, under-estimating flare in low flare conditions.
It is difficult to understand why the manufacturers
stopped producing extremely reliable models such as
the FM-500 measuring flare and the FC-2000 measur-
ing flare and cells.
When such fundamental revolutionary instruments
bringing significant medical progress are put on the
market, the responsibility of the manufacturers goes
beyond purely commercial interests. They are respon-
sible to the medical community and the patients to
assure the continuity of such an indispensible tech-
nology. We hope that slit-lamp models for LFP will
again be produced in the near future, leaving the non-
slit-lamp models for studies where more standardized
conditions prevail.
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